Cigna is trading at $285.73 (4.1% down), extending a multi-day pullback from recent gains despite the absence of fresh, company-specific headlines.
- The move appears driven by general market volatility and lingering sentiment rather than a distinct new catalyst.
- Recent investor focus has centered on regulatory scrutiny of pharmacy benefit managers (PBMs) and recent index changes.
- The stock continues to face pressure following past earnings-related drops and broader sector headwinds.